End Stage Renal Disease on Dialysis (Diagnosis)
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis
Targeted Deprescribing in Patients on Hemodialysis
Blood Pressure Lowering in Dialysis (BOLD) Trial
Comparison of High-Flow Hemodialysis Catheters Placed From the Left Internal Jugular Vein(R12-022)
Developing an Arts-based Intervention for Patients With End-stage Kidney Disease Whilst Receiving Haemodialysis
Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis